Coca-Cola beats estimates, widening gap with Pepsi in Q1 earnings

Coca‑Cola reported first‑quarter revenue of $12.47 billion, up 12.07% year‑over‑year, and earnings per share of $0.86, topping the $0.81 consensus; PepsiCo’s revenue rose 8.5% to $19.44 billion but its EPS of $1.61 missed the $1.54 estimate, widening the earnings gap between the two rivals【2】.

Diverging growth drivers

Coca‑Cola’s strength came from its Zero Sugar line, which delivered a uniform 13% volume increase across all regions, signaling a successful shift toward low‑calorie beverages【2】. By contrast, PepsiCo’s modest 2.6% organic revenue growth was driven largely by non‑U.S. snack and food segments—EMEA revenue jumped 18% and Latin America foods rose 16%—while its North American snack business barely inched up 2%【2】. The differing product mixes highlight Coca‑Cola’s focus on a concentrated beverage model versus PepsiCo’s broader, snack‑heavy portfolio.

Strategic positioning and market implications

Coca‑Cola continues to streamline its operations, refranchising bottling and pursuing the sale of its African beverage arm, reinforcing an “asset‑light” concentrate model that supports higher margins【2】. PepsiCo, still owning its snack manufacturing and pursuing affordability promotions, maintains a “full‑stack” approach that caps margins around 17% but offers two revenue engines【2】. Analysts have raised Coca‑Cola’s price target to $90, citing its 10% organic sales growth, while PepsiCo’s 54‑year dividend streak provides a defensive cushion despite the slower turnaround【2】.

Competitive landscape beyond beverages

The rivalry now extends into health‑focused categories. Coca‑Cola dominates the U.S. diet‑cola market, with Diet Coke consumption roughly 2.5 times that of Diet Pepsi【1】, and is expanding into functional drinks and ready‑to‑drink coffee. PepsiCo’s recent $2 bn acquisition of prebiotic soda brand Poppi reflects its push into “better‑for‑you” beverages, but the snack segment remains vulnerable to shifting consumer habits and the rise of weight‑loss drugs that cut soft‑drink demand by about 7% among users【1】.

What to watch

• Coca‑Cola’s upcoming guidance on comparable EPS growth for the next quarter, which will test the sustainability of its 10% organic sales pace.
• PepsiCo’s North American snack volume trends in the next earnings release, especially whether the modest 2% growth can translate into pricing power without deeper discounts.
• The impact of the pending sale of Coca‑Cola Beverages Africa on the company’s balance sheet and earnings outlook, expected to close in the second half of 2026.

Coca‑Cola’s stronger earnings and focused beverage strategy have widened its performance lead over PepsiCo, but the ultimate test will be whether Pepsi’s snack‑centric turnaround can offset the growing consumer shift toward healthier, low‑calorie options.